Pharmacy Pearls: 2023 Bivalent COVID-19 Vaccine Guidance

May 12th, 2023 | Pharmacy Pearls•Infectious Diseases

This multi-page pharmacy pearl provides guidance from the Centers for Disease Control and Prevention (CDC) and the American Academy of Pediatrics (AAP) on bivalent COVID-19 vaccine use in adult and pediatric populations. Links to both organizations are embedded throughout the document for individuals wanting more detail on the guidance. This guidance reflects the recent expiration of emergency use authorizations (EUAs) for monovalent COVID-19 vaccines. Additional information on New York State guidance for the treatment of expired or unauthorized vaccines is available here.

As always, we welcome any questions or feedback you may have. Just email the Pharmacy Team.

Taking too long?

Reload document

Open in new tab

Download PDF [869.72 KB]

135 Corporate Woods, Suite 320
Rochester, New York 14623-1466

Phone: (585) 758-7823
Fax: (585) 424-1268

Website by:

This is not an offer to purchase or a solicitation of an offer to purchase any securities or interest in Accountable Health Partners, LLC (AHP). An offer will only be made by means of a confidential private placement memorandum and subscription agreement.

ABI Value	Interpretation	Recommendation
Greater than 1.4	Calcification/vessel hardening	Refer to vascular specialist
1.0 - 1.4	Normal	None
0.9 - 1.0	Acceptable	None
0.8 - 0.9	Some arterial disease	Treat risk factor
0.5 - 0.8	Moderate arterial disease	Refer to vascular specialist
Less than 0.5	Severe arterial disease	Refer to vascular specialist

Pharmacy Pearls: 2023 Bivalent COVID-19 Vaccine Guidance

Pharmacy Pearls: 2023 Bivalent COVID-19 Vaccine Guidance

GENERAL COVID-19 INFORMATION